@intmedpressBrowse Articles
Additional files for manuscripts published before Volume 14 Issue 6 can be found via the abstract link.
Articles published electronically ahead of print and our archive from Volume 4 Issue 1 to Volume 23 Issue 7 can be found below. Articles published earlier will be made available as soon as possible. If you require an article that cannot be found below, please contact the Editorial Office.
Case report
Optimizing concentrations of concomitant antiretrovirals by reducing etravirine doses: two case reports of complex drug–drug interactions
Jean-Simon Denault, Jean-François Cabot, Hugo Langlois, Suzanne Marcotte, Nancy L Sheehan
Antiviral Therapy 2019; 24:73-76
Free
Short communication
Increased dose of dolutegravir as a potential rescue therapy in multi-experienced patients
Davide Ferrari, Vincenzo Spagnuolo, Monica Manca, Alba Bigoloni, Camilla Muccini, Giuseppe Banfi, Massimo Locatelli, Antonella Castagna
Antiviral Therapy 2019; 24:69-72
Short communication
A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients
Arturo Ciccullo, Gianmaria Baldin, Amedeo Capetti, Stefano Rusconi, Gaetana Sterrantino, Gabriella d’Ettorre, Manuela Colafigli, Sara Modica, Filippo Lagi, Andrea Giacomelli, Maria Vittoria Cossu, Sibilla Restelli, Andrea De Luca, Simona Di Giambenedetto
Antiviral Therapy 2019; 24:63-67
Original article
Frailty as a predictor of falls in HIV-infected and uninfected women
Anjali Sharma, Donald R Hoover, Qiuhu Shi, Deborah R Gustafson, Michael W Plankey, Phyllis C Tien, Kathleen M Weber, Michael T Yin
Antiviral Therapy 2019; 24:51-61
Free
Original article
Differential extracellular, but similar intracellular, disposition of two tenofovir formulations in the male genital tract
Julie B Dumond, Stephen A Greene, Heather MA Prince, Jingxian Chen, Brian M Maas, Craig Sykes, Amanda P Schauer, Kimberly H Blake, Julie AE Nelson, Cynthia L Gay, Angela DM Kashuba, Myron S Cohen
Antiviral Therapy 2019; 24:45-50
Free
Original article
Daclatasvir and sofosbuvir with ribavirin for 24 weeks in chronic hepatitis C genotype-3-infected patients with cirrhosis: a Phase III study (ALLY-3C)
Fred Poordad, Mitchell L Shiffman, Wayne Ghesquiere, Alexander Wong, Gregory D Huhn, Florence Wong, Alnoor Ramji, Stephen D Shafran, Fiona McPhee, Rong Yang, Stephanie Noviello, Misti Linaberry, the ALLY-3C study team
Antiviral Therapy 2019; 24:35-44
Original article
Autophagy involved in antiviral activity of sodium tanshinone IIA sulfonate against porcine reproductive and respiratory syndrome virus infection in vitro
Na Sun, Panpan Sun, Mingjie Yao, Ajab Khan, Yaogui Sun, Kuohai Fan, Wei Yin, Hongquan Li
Antiviral Therapy 2019; 24:27-33
Free
Original article
Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting
Farah Ladak, Eugenia Socias, Seonaid Nolan, Huiru Dong, Thomas Kerr, Evan Wood, Julio Montaner, M-J Milloy
Antiviral Therapy 2019; 24:19-25
Original article
Effectiveness of 8 weeks of ledipasvir/sofosbuvir for hepatitis C in HCV–HIV-coinfected patients
Ana D Vega, Lauren M Hynicka, Kimberly Claeys, Joel V Chua, Emily L Heil
Antiviral Therapy 2019; 24:11-17
Review
Sofosbuvir/velpatasvir/voxilaprevir: a highly effective option for retreatment of hepatitis C in difficult-to-treat patients
Poonam Mathur, Shyamasundaran Kottilil, Eleanor Wilson
Antiviral Therapy 2019; 24:1-10